Tech Nation + BioTech Nation + Global BioEntrepreneurship
Episode 25-47
Air Date: December 4, 2025
On this week’s Tech Nation, Moira speaks with Dr. Ashley Shew, Professor of Science, Technology, and Society at Virginia Tech and author of, "Against Technoableism... Rethinking Who Needs Improvement", about how technology influences our perception of disability and whether it truly helps those it aims to support. Then, Dr. Ari Azhir, CEO of Neuvivo, discusses how her company revived a once-failed ALS drug by re-examining clinical trial data, uncovering its potential to treat Huntington’s, Alzheimer’s, and Vascular Dementia.
Episode 25-46Air Date: November 28, 2025
On this week’s Tech Nation, Moira speaks with Sonia Purnell about her book, “A Woman of No Importance,” and the story of Virginia Hall, an American spy who operated in Nazi-occupied France during World War II, even with her wooden leg. Then, Dr. Lincoln Nadauld, President & CEO of Culmination Bio, discusses how medical records and biological data are being combined with technology to answer unprecedented questions in medicine.
Episode 25-45Air Date: November 20, 2025
On this week’s Tech Nation, Moira speaks with Terry Healey about "The Resilience Mindset … How Adversity Can Strengthen Individuals, Teams, and Leaders". Then Lisa Dechamps tell us how Aviado Bio is working to correct the gene driving many cases of frontotemporal dementia. And Columbia University professor Dr. Sandra Matz describes the science of psychological targeting”.
BioTech Nation
PODCASTS
December 4, 202
Are we moving from Dr. Google to
Dr. ChatGPT???
Dr. Daniel Kraft
Tech Nation Health
Chief Correspondent
For years, we've all turned to Google to self-diagnose every cough, rash, and weird pain. This week on Biotech Nation, Dr. Daniel Kraft says the shift is happening, from Dr. Google to Dr. ChatGPT.
November 25, 2025
Dr. Lincoln NadauldPresident & CEO Aviado Bio
- This week on Biotech Nation, Dr. Lincoln Nadauld shares how Culmination Bio is using 9 million preserved tissue samples and decades of patient data to improve how we understand and treat diseases. From discovering patterns in cancer treatments to exploring breakthroughs in heart and autoimmune diseases, this unique approach is changing medicine.